Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000229443 | SCV000285543 | likely benign | Werner syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000229443 | SCV000473338 | uncertain significance | Werner syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Gene |
RCV001357192 | SCV001801299 | likely benign | not provided | 2018-08-20 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000229443 | SCV003823795 | uncertain significance | Werner syndrome | 2022-06-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001357192 | SCV004184347 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | WRN: BP4, BS2 |
Department of Pathology and Laboratory Medicine, |
RCV001357192 | SCV001552578 | likely benign | not provided | no assertion criteria provided | clinical testing | The WRN p.I912S variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs11574323) and ClinVar (classified as uncertain significance by Illumina and as likely benign by Invitae). The variant was identified in control databases in 122 of 267578 chromosomes (3 homozygous) at a frequency of 0.0004559 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 99 of 30486 chromosomes (freq: 0.003247), Ashkenazi Jewish in 7 of 9846 chromosomes (freq: 0.000711), Other in 1 of 6662 chromosomes (freq: 0.00015), European (non-Finnish) in 13 of 117852 chromosomes (freq: 0.00011), European (Finnish) in 1 of 25098 chromosomes (freq: 0.00004) and Latino in 1 of 35006 chromosomes (freq: 0.000029), but was not observed in the African or East Asian populations. The p.I912 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |